About EPS Group
Electrical & Pumping Services (EPS) Australia offers a suite of services that encompass involvement in electrical projects from design, specification, construction, testing, commissioning, and energization to operations and maintenance.
Missing: EPS Group's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: EPS Group's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest EPS Group News
Oct 7, 2022
10/07/2022 | 03:22am EDT Message : Contact Person: GNI forms joint venture with EPS in Japan focusing on medical device business GNI Group Ltd. (the Group) is pleased to announce that it has signed a binding MOU to form a joint venture (JV) with a unit of EPS Group (Shinjuku-ku, Tokyo; Representative Director: Hao Yan; hereinafter "EPS"). Through the existing medical device representation services provided for offshore companies, this JV will focus on introducing foreign medical device products, including biomaterials into the Japanese market. The new JV will be 60% owned by the Group. The JV will be based in Tokyo with 9 staff and is projected to expand its staffing and customer base over time. The JV is expected to have a modest, but positive impact on the Group's financial performance and will be included accordingly under the Medical Device segment of our reported financials. We expect final details to be concluded by the end of this year or Q1 2023. This JV represents the Group's small, but first significant step to establish an operating presence in Japan. Over time we expect to expand the JV's business and customer base to take advantage of our strong presence in the US and China. The medical device/biomaterial business has been a profitable cornerstone of the Group since 2017. We intend to leverage this new JV to aim for stronger growth of our medical device/biomaterial business segment in the coming years. _______________________________________________________________________________________________ About GNI Group, Inc.: GNI Group is a global healthcare company listed on the Growth Board of the Tokyo Stock Exchange and engaged in drug discovery, pharmaceutical development, biomaterial development, clinical studies, manufacturing, and sales in both the United States and China. For more information, please visit our website below https://www.gnipharma.com/ About EPS Group: The EPS Group is a healthcare solutions provider that has been handling all processes from drug discovery and development to sales, marketing, consulting, and various other solutions since its founding as a pioneer CRO in Japan in 1991. The Group broadening its businesses as well by also engaging in initiatives to bring new value to pharmaceutical and medical device companies, hospitals, clinics, and academia through efforts that include expansion in China and the rest of Asia, big data and AI, and regenerative medicine. In 2021, the EPS Group launched an innovative medicine business and started services to support the clinical development of seeds originating at academic institutions and domestic and global biotech ventures and to support marketing in and
EPS Group Frequently Asked Questions (FAQ)
Where is EPS Group's headquarters?
EPS Group's headquarters is located at Suite 1704, Level 17, Tower 2, Sydney.
What is EPS Group's latest funding round?
EPS Group's latest funding round is Acquired.
Who are the investors of EPS Group?
Investors of EPS Group include Enermech.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.